Can we exonerate GLP-1 receptor agonists from blame for adverse pancreatic events?

Ann Transl Med. 2018 May;6(10):186. doi: 10.21037/atm.2018.03.06.

Authors

Conor F Murphy¹, Carel W le Roux^{1

2}

Affiliations

¹ Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin, Ireland.
² Gastrosurgical laboratory, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

No abstract available

Publication types

Editorial
Comment